Main
>
ONCOLOGY (**)
>
Leukemia>Lymphocytic>Chronic ***
>
Treatment
>
USA. A. Ibrutinib+ObinutuzuMAb
>
(*) USA Approval Date: 2019. 01.28.
(*) USA Approval Date: 2019. 01.28.'s products
This section has no products